XML 62 R41.htm IDEA: XBRL DOCUMENT v3.20.4
SHARE CAPITAL (Narrative) (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Apr. 30, 2020
USD ($)
Feb. 19, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
$ / shares
shares
Aug. 31, 2019
USD ($)
$ / shares
shares
May 31, 2019
$ / shares
shares
Jan. 31, 2019
$ / shares
shares
Sep. 30, 2018
USD ($)
shares
Mar. 31, 2018
$ / shares
shares
Feb. 28, 2018
USD ($)
shares
Jan. 19, 2018
$ / shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Dec. 31, 2014
₪ / shares
shares
Dec. 31, 2020
₪ / shares
Dec. 31, 2019
₪ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Ordinary shares, shares authorized     50,000,000               50,000,000 50,000,000       50,000,000
Ordinary shares, par value per share | ₪ / shares                             ₪ 0.1 ₪ 0.1
Fair value of options granted | $                       $ 485 $ 878      
Additional ordinary shares purchased                         937,500      
Procceds from Initial public offering, net of issuance costs | $                     $ 21,306 $ 10,613 $ 78,775      
Share split                   1-for-1.8            
Bonus share | $ / shares                   $ 0.8            
FPO [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Exercise price | $ / shares   $ 14                            
Ordinary shares issued   2,091,907   1,437,500                        
Per share price | $ / shares   $ 11.00   $ 8.00                        
Warrants to purchase ordinary shares   1,673,525                            
Net proceeds | $   $ 21,306   $ 10,613                        
FPO [Member] | Underwriter [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Warrants to purchase ordinary shares       187,500                        
Private Placement [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Shares issued   454,628                            
Warrants to purchase ordinary shares   363,702                            
Net proceeds | $ $ 5,000 $ 5,000                            
IPO [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Ordinary shares issued                         6,250,000      
Per share price | $ / shares                         $ 12      
Procceds from Initial public offering, net of issuance costs | $                         $ 78,775      
Outstanding promissory note converted into ordinary shares                         5,444,825      
Promissory note conversion price | $ / shares                         $ 12      
Restricted Stock Units (RSUs) [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Option grants             11,500   46,000              
Option vested                     38,332          
Fair value of options granted | $             $ 105   $ 495              
Warrants [Member] | FPO [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Ordinary shares issued   2,091,907                            
Warrants [Member] | Private Placement [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Shares issued   454,628                            
Employees [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Maximum term of awards                     10 years          
Shares available for future grant                     949,415          
Option grants     6,300   9,000                      
Exercise price | $ / shares     $ 8.32   $ 7.32             $ 8.32        
Option vesting period                     4 years          
Percentage of option vesting                     25.00%          
Unrecognized compensation cost | $                     $ 271          
Compensation costs weighted average period to be recognized                     2 years 11 months 15 days          
Board of Directors [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Ordinary shares, par value per share | ₪ / shares                           ₪ 0.1    
Odinary share issued under share incentive plan                       912,230   629,025    
Executive Officer [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Option grants           80,000                    
Exercise price | $ / shares           $ 5.95                    
Consultant Member [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Option grants               76,895                
Exercise price | $ / shares               $ 11.21                
Non Employees Member [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Option vesting period                     4 years          
Percentage of option vesting                     25.00%          
Fair value of options granted | $                         $ 648      
Unrecognized compensation cost | $                     $ 25          
Compensation costs weighted average period to be recognized                     1 year 2 months 23 days          
Intrinsic value outstanding option | $                     $ 482          
Intrinsic value exercisable option | $                     $ 413